Next Article in Journal
Singlet Oxygen in Plants: Generation, Detection, and Signaling Roles
Previous Article in Journal
Glycosylation Tunes Neuroserpin Physiological and Pathological Properties
Previous Article in Special Issue
MAP Kinases Pathways in Gastric Cancer
Open AccessReview

Targeting ERK-Hippo Interplay in Cancer Therapy

Laboratory of Structural Biology and Cell Signaling, Institute of Microbiology of the Czech Academy of Sciences, 14220 Prague, Czech Republic
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(9), 3236; https://doi.org/10.3390/ijms21093236
Received: 6 April 2020 / Revised: 26 April 2020 / Accepted: 27 April 2020 / Published: 3 May 2020
(This article belongs to the Special Issue Targeting MAPK in Cancer)
Extracellular signal-regulated kinase (ERK) is a part of the mitogen-activated protein kinase (MAPK) signaling pathway which allows the transduction of various cellular signals to final effectors and regulation of elementary cellular processes. Deregulation of the MAPK signaling occurs under many pathological conditions including neurodegenerative disorders, metabolic syndromes and cancers. Targeted inhibition of individual kinases of the MAPK signaling pathway using synthetic compounds represents a promising way to effective anti-cancer therapy. Cross-talk of the MAPK signaling pathway with other proteins and signaling pathways have a crucial impact on clinical outcomes of targeted therapies and plays important role during development of drug resistance in cancers. We discuss cross-talk of the MAPK/ERK signaling pathway with other signaling pathways, in particular interplay with the Hippo/MST pathway. We demonstrate the mechanism of cell death induction shared between MAPK/ERK and Hippo/MST signaling pathways and discuss the potential of combination targeting of these pathways in the development of more effective anti-cancer therapies. View Full-Text
Keywords: MAPK; ERK; Hippo; MST; PI3K; YAP; cancer; apoptosis; caspase; inhibitors; natural compounds; therapy MAPK; ERK; Hippo; MST; PI3K; YAP; cancer; apoptosis; caspase; inhibitors; natural compounds; therapy
Show Figures

Figure 1

MDPI and ACS Style

Vališ, K.; Novák, P. Targeting ERK-Hippo Interplay in Cancer Therapy. Int. J. Mol. Sci. 2020, 21, 3236.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop